Advisors Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$342K Sell
5,650
-1,457
-21% -$84.9K 0.06% 127
2025
Q4
$383K Sell
7,107
-258
-4% -$12.4K 0.07% 115
2025
Q3
$332K Buy
7,365
+355
+5% +$16.6K 0.06% 123
2025
Q2
$324K Buy
7,010
+25
+0.4% +$1.23K 0.06% 121
2025
Q1
$426K Buy
6,985
+1
+0% +$58 0.09% 107
2024
Q4
$395K Sell
6,984
-25
-0.4% -$1.4K 0.09% 111
2024
Q3
$363K Buy
7,009
+1
+0% +$47 0.09% 117
2024
Q2
$291K Sell
7,008
-118
-2% -$5.28K 0.07% 129
2024
Q1
$386K Sell
7,126
-391
-5% -$19.9K 0.1% 112
2023
Q4
$386K Sell
7,517
-200
-3% -$10.5K 0.1% 109
2023
Q3
$448K Buy
7,717
+1,281
+20% +$78.5K 0.14% 99
2023
Q2
$412K Hold
6,436
0.12% 99
2023
Q1
$446K Sell
6,436
-128
-2% -$9.03K 0.14% 92
2022
Q4
$472K Buy
6,564
+87
+1% +$6.56K 0.18% 81
2022
Q3
$460K Buy
6,477
+77
+1% +$5.59K 0.18% 81
2022
Q2
$493K Buy
6,400
+188
+3% +$14.3K 0.17% 82
2022
Q1
$454K Sell
6,212
-184
-3% -$12.4K 0.15% 82
2021
Q4
$399K Buy
6,396
+271
+4% +$15.9K 0.12% 89
2021
Q3
$362K Sell
6,125
-152
-2% -$10K 0.11% 92
2021
Q2
$419K Buy
6,277
+1,960
+45% +$128K 0.12% 91
2021
Q1
$273K Buy
+4,317
New +$269K 0.09% 102

Other funds holding BMY

Advisors Management Group's BMY Position: Q1 2026 in Review

Advisors Management Group reduced its Bristol-Myers Squibb (BMY) stake by 21% in Q1 2026, selling an estimated $84.9K and leaving 5,650 shares worth $342K. The position accounts for 0.06% of the portfolio, ranked #127.

Advisors Management Group first reported a position in BMY in Q1 2021 and has held it in 21 quarters since. The position peaked at $493K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Advisors Management Group held 5,650 shares of Bristol-Myers Squibb worth $342K as of Q1 2026.
  • Advisors Management Group sold 1,457 Bristol-Myers Squibb shares in Q1 2026, an estimated $84.9K.
  • Bristol-Myers Squibb made up 0.06% of Advisors Management Group's portfolio in Q1 2026, its #127 holding.
  • Advisors Management Group first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 21 quarters since.
  • Advisors Management Group's Bristol-Myers Squibb position peaked at $493K in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Advisors Management Group's 13F filing for Q1 2026, filed 1 May 2026.